Elligo Health Research will test a harmonized real-word data model built by the FDA.
As part of our video series for this year’s DDF 2017 event, life science leaders spoke to us about CRO needs and new regulations.
The careful optimization of tumor-bearing humanized models leads to highly useful preclinical immuno-oncology platforms for accelerated immunotherapy…
PPD has taken on a former FDA veteran, Jonca Bull, M.D., as its new VP of PPD consulting and ophthalmology within global product development.
Biopharma executives share how they manage outsourcing relationships at this year's Drug Development Forum.
Parexel has set up a team committed to providing real-world data insights.
The FDA and its new Trump-picked commissioner Scott Gottlieb took to social media to talk up plans to speed up the drug regulation process.
China's FDA is proposing new policies to hasten clinical trial approval and lift restrictions placed on trial sites.
PPD has put its medical affairs research operations team under Evidera, the evidence-based solutions subsidiary PPD bought last year.
China's FDA and Supreme Court, in a seemingly synchronized move, are proposing new actions against forging clinical trial data, and criminal charges are…
Texas-based Moleculin Biotech penned a deal with Theradex Systems to help it run early-stage trials for its candidate annamycin in acute myeloid leukemia.